pcr
accept
rapid
diagnost
test
current
avail
naat
extens
valid
cultur
sensit
naat
almost
alway
superior
tradit
procedur
consid
new
gold
standard
increas
bodi
literatur
describ
use
inhous
naat
detect
pneumonia
dna
rna
variou
diseas
avail
great
variat
method
use
studi
studi
includ
variabl
target
adhesin
gene
rrna
atpas
gene
proteas
gene
card
toxin
gene
naat
convent
nest
realtim
monoplex
vs
multiplex
pcr
vs
isotherm
amplif
technolog
detect
format
differ
platform
overview
literatur
use
naat
detect
pneumonia
sinc
given
two
review
loen
et
al
late
effort
mainli
emphas
develop
multiplex
assay
nummi
et
al
shen
et
al
evalu
commerci
avail
assay
respiratori
virus
call
atyp
bacteria
respons
rti
may
produc
clinic
similar
manifest
order
reduc
cost
handsontim
multiplex
naat
simultan
detect
differ
respiratori
pathogen
one
tube
mixtur
primer
develop
group
howev
comparison
monoand
multiplex
assay
rare
perform
find
conclus
result
frequent
contradictori
conflict
data
concern
sensit
specif
multiplex
naat
compar
mono
naat
unexpect
sinc
presenc
sever
pair
primer
may
increas
probabl
mispair
result
nonspecif
amplif
product
format
primerdim
furthermor
enzym
primer
salt
concentr
well
temperatur
cycl
requir
target
may
slightli
differ
result
profici
panel
loen
et
al
describ
previous
seem
confirm
multiplex
assay
somewhat
less
sensit
monoplex
assay
number
organ
present
clinic
specimen
diseas
individu
known
imposs
state
whether
degre
sensit
attain
clinic
accept
sinc
previou
review
ieven
loen
new
naat
becam
commerci
avail
illumigen
meridian
bioscienc
usa
kit
propos
industryproduc
assay
kit
form
result
better
standard
analyt
sensit
illumigen
assay
evalu
use
frozen
stock
cultur
pneumonia
refer
strain
collect
microorgan
human
dna
ratliff
et
al
serial
dilut
cultur
known
cfuml
defin
analyt
sensit
cfuml
base
result
obtain
archiv
respiratori
specimen
previous
cultur
pneumonia
clinic
sensit
specif
found
respect
resolv
discrep
pcr
sequenc
second
exampl
test
approv
detect
number
respiratori
virus
us
food
drug
administr
filmarray
respiratori
panel
franc
filmarray
small
desktop
close
singlepiec
flow
realtim
pcr
system
includ
autom
nucleic
acid
extract
initi
revers
transcript
multiplex
pcr
follow
singleplex
second
stage
pcr
reaction
detect
viral
agent
includ
adenoviru
coronaviru
coronaviru
human
metapneumoviru
rhinovirusenteroviru
influenza
ab
influenza
parainfluenza
respiratori
syncyti
viru
poritz
et
al
may
us
food
drug
administr
expand
use
filmarray
respiratori
panel
addit
b
pertussi
pneumonia
c
pneumonia
expand
panel
detect
total
virus
three
bacteria
test
requir
min
handsontim
min
instrument
time
new
version
filmarray
version
releas
doern
et
al
argen
respiratori
mwsrgene
concept
allow
detect
numer
pathogen
influenza
ab
respiratori
syncyti
virushuman
metapneumoviru
rhinovirusenteroviru
adenovirusbocaviru
chlamydiamycoplasma
pneumonia
human
coronavirusparainfluenza
viru
bordetella
bordetella
parapertussi
run
addit
diagnost
strategi
adapt
season
search
like
pathogen
consid
stage
remain
pathogen
search
systemat
stage
pillet
et
al
compar
six
commerci
avail
multiplex
assay
diagnosi
respiratori
pathogen
two
six
also
capabl
detect
pneumonia
respifind
smart
pathofind
netherland
seeplex
onestep
ace
detect
pneumobact
ace
detect
seegen
inc
south
korea
sensit
specif
calcul
argenechlamyco
pneumo
assay
franc
sensit
specif
respect
respifind
assay
seegen
assay
dumk
et
al
compar
four
commerci
avail
realtim
pcr
assay
recommend
use
roch
lightcycl
instrument
diagenod
mycoplasmachlamydophila
pneumonia
realtim
pcr
diagenod
belgium
geneproof
pneumonia
geneproof
czech
republ
bactor
pneumonia
ingenetix
austria
lightmix
kit
pneumonia
tib
molbiol
germani
detect
pneumonia
result
obtain
inhous
approach
dumk
jacob
use
serial
dilut
cultur
pneumonia
strain
test
eight
parallel
run
clinic
specimen
previous
found
pneumonia
posit
inhous
assay
naat
detect
coloni
form
unit
cfu
sampl
inhousetest
approach
abl
detect
sampl
pneumonia
posit
clinic
specimen
confirm
diagenod
test
ingenetix
lightmix
assay
geneproof
assay
respect
overview
commerci
avail
naat
detect
pneumonia
present
tabl
sinc
calcul
sensit
commerci
multiplex
assay
mainli
depend
dna
copi
number
evalu
standard
use
extend
number
clinic
specimen
may
low
bacteri
load
need
use
intern
standard
develop
harmon
mycoplasma
naat
et
al
yearli
particip
extern
qualiti
assess
eqa
panel
pneumonia
chlamydophila
pneumonia
avail
qualiti
control
molecular
diagnost
qcmd
unit
kingdom
consid
far
unclear
whether
asymptomat
carriag
pneumonia
adult
children
exist
colon
could
differenti
infect
current
diagnost
method
data
relat
bacteri
load
sever
infect
asymptomat
children
children
rti
enrol
crosssect
studi
spuesen
et
al
nasopharyng
wash
pharyng
swab
investig
cultur
quantit
realtim
pcr
qpcr
serum
collect
igm
igg
elisa
neither
qpcr
serolog
cultur
capabl
differenti
colon
infect
asymptomat
symptomat
children
pneumonia
dna
detect
addit
persist
pneumonia
upper
respiratori
tract
shown
month
longitudin
sampl
retrospect
studi
investig
clinic
signific
pneumonia
bacteri
load
children
pneumonia
pneumonia
jiang
et
al
author
conclud
high
bacteri
load
indic
pneumonia
infect
wherea
low
bacteri
load
etiolog
role
pneumonia
remain
determin
edin
et
al
develop
qpcr
duplex
reaction
target
eight
bacteria
includ
pneumonia
six
virus
edin
et
al
clinic
specimen
upper
lower
respiratori
tract
use
compar
qpcr
assay
standard
microbiolog
method
use
qpcr
assay
result
posit
identif
respiratori
specimen
compar
use
standard
diagnost
author
conclud
parallel
qpcr
detect
target
respiratori
bacteria
virus
feasibl
sinc
good
technic
perform
assay
clinic
specimen
obtain
contrast
mention
studi
jain
et
al
examin
specimen
hospit
children
communityacquir
pneumonia
asymptomat
control
detect
varieti
respiratori
pathogen
pneumonia
detect
less
control
anoth
trend
simultan
detect
pneumonia
mutat
associ
macrolid
resist
directli
clinic
specimen
ji
et
al
liu
et
al
nummi
et
al
zhao
et
al
serolog
method
particular
enzymelink
immunosorb
assay
elisa
wide
use
diagnos
pneumonia
infect
complement
fixat
test
cft
replac
assay
allow
quantif
igm
iga
igg
howev
convinc
evid
ongo
infect
signific
increas
igg
igg
seroconvers
pair
sera
collect
week
apart
nirpaz
et
al
although
igm
antibodi
appear
earlier
igg
antibodi
thu
attract
altern
diagnosi
pneumonia
infect
one
realiz
igm
often
produc
young
children
proport
primari
infect
reinfect
wait
et
al
loen
et
al
ten
serolog
assay
diagnosi
pneumonia
infect
recent
evalu
use
sera
patient
busson
et
al
seromp
igm
igg
savyon
diagnost
seromp
recombin
igm
iga
igg
savyon
diagnost
liaison
pneumonia
igm
igg
biotrin
intern
ltd
pneumonia
igm
iga
igg
medac
medac
gmbh
low
igm
specif
crossreact
notic
seromp
recombin
liaison
assay
iga
medac
assay
tend
less
specif
seromp
recombin
assay
four
test
show
discrep
igg
measur
confirm
result
previou
studi
talkington
et
al
beersma
et
al
conclus
serolog
remain
diagnost
tool
choic
improv
standard
assay
still
need
especi
determin
igg
clinic
signific
serolog
test
igm
igg
defin
studi
patient
document
infect
detail
inform
concern
time
laps
onset
diseas
collect
serum
specimen
known
promis
blot
techniqu
improv
perform
pneumonia
serolog
assay
describ
dumk
et
al
data
recent
studi
use
pcr
base
method
serolog
publish
last
decad
differ
patient
popul
around
world
summar
recent
review
publish
ieven
loen
loen
et
al
ieven
loen
updat
tabl
avail
sensit
naat
recent
year
also
put
often
use
serolog
test
right
perspect
allow
better
interpret
serolog
test
result
limit
low
sensit
igm
antibodi
acut
phase
specimen
import
delay
two
serum
sampl
studi
also
naat
use
respiratori
specimen
allow
better
interpret
serolog
test
result
rapid
respons
report
canadian
agenc
drug
technolog
health
canadian
agenc
drug
technolog
health
present
result
literatur
search
order
identifi
diagnost
test
accuraci
clinic
effect
costeffect
serum
igm
molecular
test
detect
pneumonia
patient
respiratori
six
relev
studi
identifi
evid
regard
clinic
effect
costeffect
serum
igm
test
compar
molecular
test
identifi
zhang
et
al
conduct
systemat
review
metaanalysi
diagnosi
pneumonia
pcr
serolog
zhang
et
al
report
signific
heterogen
studi
inconsist
result
well
two
studi
compar
applic
realtim
pcr
serolog
children
pneumonia
children
found
posit
pcr
chang
et
al
pneumonia
igm
posit
patient
found
pneumonia
posit
test
time
use
pcr
gold
standard
sensit
specif
resp
obtain
specif
could
increas
increas
cutoff
without
chang
sensit
igm
assay
studi
conduct
medjo
et
al
appli
pcr
cultur
igm
igg
pair
sera
detect
pneumonia
infect
children
use
igg
serolog
gold
standard
sensit
igm
pcr
cultur
found
equal
specif
found
respect
conclud
acut
phase
diseas
detect
igm
antibodi
combin
pcr
allow
precis
reliabl
pneumonia
diagnosi
prospect
studi
children
communityacquir
cap
kakuya
et
al
compar
loopmedi
isotherm
amplif
lamp
cultur
serolog
first
visit
patient
defin
posit
posit
cultur
andor
seroconvers
fourfold
increas
igg
pair
sera
patient
met
criteria
thirteen
posit
cultur
serolog
cultur
one
serolog
posit
lamp
result
obtain
patient
cultur
posit
sensit
specif
lamp
eia
particl
agglutin
test
respect
establish
etiolog
adult
cappati
norway
found
pneumonia
posit
two
serolog
seven
one
pcr
appli
nasopharyng
flock
swab
oropharyng
flock
swab
respect
holter
et
al
newer
technolog
microfluid
applic
nanotechnolog
offer
potenti
even
rapid
detect
import
pathogen
allow
even
nearpati
test
sinc
technolog
naat
requir
viabl
organ
thu
avoid
advers
effect
longer
specimen
transport
success
appli
outpati
set
sever
compani
current
possess
technic
expertis
research
infrastructur
bring
use
diagnost
test
approach
clinic
trial
stage
shortli
li
et
al
develop
colloid
goldbas
immunechromatograph
assay
use
pair
monoclon
antibodi
target
region
gene
appli
clinic
specimen
children
suspect
pneumonia
infect
sensit
specif
realtim
pcr
contrast
result
obtain
commerci
avail
rapid
antigen
test
target
ribosom
protein
ribotest
mycoplasma
compar
realtim
pcr
sensit
specif
respect
obtain
appli
clinic
specimen
miyashita
et
al
base
result
author
conclud
treatment
decis
taken
base
ribotest
result
alon
amplificationfre
detect
methodolog
current
develop
biosens
detect
strategi
prototyp
enzymefre
electrochem
genosensor
nanostructur
screenprint
gold
electrod
garciagonzalez
et
al
silver
nanorod
arraysurfac
enhanc
raman
spectroscopi
biosens
platform
success
appli
detect
pneumonia
simul
clinic
throat
swab
henderson
et
al
use
tool
naat
greater
understand
etiolog
epidemiolog
pneumonia
possibl
taken
account
result
obtain
recent
studi
evid
realtim
naat
superior
pneumonia
detect
strategi
earli
phase
infect
naat
howev
complet
replac
serolog
epidemiolog
studi
serolog
certainli
use
manag
individu
patient
lrti
even
cap
sinc
result
often
delay
need
pair
sera
detect
seroconvers
signific
rise
titer
earli
cours
infect
falseneg
result
often
occur
case
specif
igm
test
use
serolog
complet
abolish
despit
fact
igm
serolog
show
moder
sensit
nowaday
combin
detect
igm
antibodi
pcr
may
optim
approach
earli
diagnosi
pneumonia
infect
especi
children
implement
quantit
test
could
shed
light
relat
bacteri
load
serious
diseas
produc
use
prognost
inform
help
differenti
colon
infect
inform
could
gather
length
post
infect
carrier
state
well
import
subclin
infect
prone
spread
infect
remain
import
recogn
urgent
need
adopt
unifi
consist
diagnost
approach
current
futur
investig
therefor
common
set
recommend
develop
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
